Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 04:23 ET | Source: Research and Markets

Rituxan Hycela, Rituxan Mabthera (Rituximab) Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Rituxan Hycela, Rituxan Mabthera (Rituximab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added...
March 18, 2025 10:45 ET | Source: Research and Markets

Lymphoma Therapeutics Strategic Business Research Report 2024-2030 by Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Revlimid, Rituxan/MabThera, Imbruvica, Keytruda, Adcetris, Other Drugs

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Lymphoma...
February 08, 2024 09:36 ET | Source: Research and Markets

Diffuse Large B-Cell Lymphoma Therapeutics Market Forecast to Reach $6.49 Billion by 2028 Amid Advancements in Personalized Medicine and Treatment Innovations

Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. As the global community...
May 02, 2023 07:33 ET | Source: Research and Markets

Leukemia Therapeutics Global Market Report 2023: Rises in Product Approvals and Increasing Diagnosis Awareness Drives Growth

Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Leukemia Therapeutics Market by Type, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
April 12, 2023 12:43 ET | Source: Research and Markets

Lymphoma Therapeutics Global Market to Reach $25.2 Billion by 2030: Artificial Intelligence Helps Speed up & Automate Lymphoma Diagnosis

Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Lymphoma...
October 26, 2022 09:43 ET | Source: Research and Markets

Lymphoma Treatment Global Market Report 2022: Technological Advancements, Including the Development of Innovative Immune Checkpoint Inhibitors, Fuel Growth

Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
December 01, 2021 07:53 ET | Source: Research and Markets

Worldwide Lymphoma Treatment Industry to 2026 - Featuring Abbott Laboratories, Novartis and Spectrum Pharmaceuticals Among Others

Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
September 28, 2021 04:33 ET | Source: Research and Markets

Global Non-Hodgkin Lymphoma (NHL) Therapeutics Markets, 2016-2020 & 2021-2026 by Type of Therapy, Cell Type, Drug Type, & Distribution Channel

Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market, By Type of Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Stem Cell Transplant,...
July 06, 2021 08:08 ET | Source: Research and Markets

Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027

Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
May 13, 2021 05:53 ET | Source: Research and Markets

China Rituximab Market Report 2021-2025: A Monoclonal Antibody to Target Cells that have the CD20 Marker on their Surface

Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Rituximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to this market...

Next Page keyboard_arrow_right